期刊文献+

肺硬化性血管瘤21例临床病理分析 被引量:3

Sclerosing hemangioma of the lung:a clinicopathologic analysis of 21 cases
下载PDF
导出
摘要 目的探讨肺硬化性血管瘤(sclerosing hemangioma of the lung,SHL)的临床病理特征。方法对21例SHL进行HE染色及免疫组织化学染色,光镜观察。结果本组男4例,女17例,年龄19~65岁,平均42.8岁。HE染色示:SHL主要由实性片块区、乳头状区、血管瘤样区和硬化区4种组织结构组成,瘤细胞有2种即被覆乳头表面、实性区裂隙及血管样腔面的立方细胞和实性区及乳头轴心大小形态一致的多角形细胞;免疫组化染色示:2种细胞均表达EMA和TTF-1,立方细胞表达CK;而多角形细胞弥漫表达vimentin、ER、PR,部分表达Syn、CgA和NSE。结论SHL多见于中青年女性,发病率低,易误诊为肺癌。典型的组织形态特征结合TTF-1、EMA、CK、vimentin等免疫组化染色,是诊断和鉴别诊断SHL的主要方法;ER、PR的高表达可能与女性的高发病率密切相关。 Purpose To describe the clinicopathologic features of sclerosing hemangioma of the lung (SHL). Methods 21 cases of SHL were studied by HE stain and immunohistochemical stains and light microscopy. Results There were 4 males and 17 females in this group and aged from 19 to 65 years with the average of 42. 8. HE staining revealed that SHL showed a mixture of the following four histological patterns: solid,papillary,hemangioma-like and sclerotic. There were two types of tumor cells: cuboidal cells covered the papillary surface, and lined fissure-cavity in the solid and vascular areas, and polygonal cells with consistent size and morphology in the solid areas and papillary axis. Immunohistochemical staining revealed that the surface of the cuboidal cells expressed TTF-1, CK, and EMA, and the polygonal cells expressed TTF-1, vimentin, ER, PR, NSE, and CgA. Conclusions SHL is particularly prevalent in young and middle-aged women, The incidence rate is low and often misdiagnosed as lung cancer. Morphological analyses and immunohistochemical stains are the main approaches for the diagnosis and differential diagnosis. Expression of ER and PR correlates with predisposition of this tumor to women.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2009年第4期379-381,386,共4页 Chinese Journal of Clinical and Experimental Pathology
关键词 肺肿瘤 硬化性血管瘤 临床病理学 免疫组织化学 lung neoplasms sclerosing hemangioma clinical pathology immunohistochemistry
  • 相关文献

参考文献14

二级参考文献71

共引文献181

同被引文献18

  • 1王妍,戴顺东,王恩华.所谓肺硬化性血管瘤组织中两种主要细胞的基因表达差异及意义[J].中国肺癌杂志,2007,10(6):466-470. 被引量:13
  • 2袁素,龚选举,万珍玲.肺硬化性血管瘤临床病理分析(附5例报道并文献复习)[J].中国热带医学,2007,7(8):1378-1379. 被引量:1
  • 3Ohgaki H, Kteihues P. Genetic pathway to primary and secondary glioblastomas[ J]. Am J Patho1,2007 (170) : 1445 - 1453. 被引量:1
  • 4祁敏现,吉庆明,盛喜玲.肺硬化性血管瘤的临床病理学研究[J].医药论坛杂志,2007,28(21):3-5. 被引量:1
  • 5Liebow AA, Hubbell DS. Sclerosing hemangioma( histocytoma, xanthoma) of the lung[J]. Cancer,1956,9(1) :53. 被引量:1
  • 6Zhang J,Wang CL. Diagnosis and surgical treatment for solitary pulmonary nodule of pulmonary sclerosing hemangioma [J ]. Zhong guo Xian Dai Yi Xue Za Zhi,2009,19(8):1268. 被引量:1
  • 7Devouassoux SM, Hayashi T, Linnoila RI, et al. A clinicopatho- logic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium [J]. Am J Surg Pathol,2000,24(7) :906. 被引量:1
  • 8Chiba W, Sawais, Yasuda Y, et al. Positive expression of c-myc and p53 products in two cases of pulmonary sclerosing hemangio- ma[J]. Nippon kyobu Shikkan Gakkai Zasshi, 1995, 33 (12) 1348. 被引量:1
  • 9Dacic S, Sasatomi E, Swalsky PA, et al. Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloal- veolar carcinoma indicate a similar molecular pathogenesis[J]. Arch Pathol Lab Med, 2004,128 (8) : 880. 被引量:1
  • 10Iyoda A, Baba M, Saitoh H, et al. Imprint cytologic features of pulmonary selerosing hemangioma: comparison with well-differ- entiated papillary adenocarcinoma[J].Cancer, 2002,96 : 146. 被引量:1

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部